Neurology

• B.A., Thomas More College, Ft. Mitchell, KY, 1969
• M.S., Eastern Kentucky University, Richmond, KY, 1979
• Ph.D., Southern Illinois University, Carbondale, IL, 1987

Work History

1986-1987, Project Coordinator, Housing Options for Seniors Today, Department of Consumer Economics & Housing, Cornell University

1985, Assistant Editor, Journal of Studies in Technical Careers, School of Technical Careers, Southern Illinois University

1981-1982, Research Assistant, Maternal and Child Health, School of Hygiene, Johns Hopkins University

1979-1981, Project Coordinator, Project 12 Ways, Rehabilitation Institute, Southern Illinois University

1976-1979, Counselor, Bluegrass East Comprehensive Care Center, Lexington, KY

Clinical Specialties

Coordinating multi-center clinical trials for neurological disorders, with special interest in Parkinson’s and Huntington’s disease

Highlights

Society for Clinical Trials
Association of Clinical Research Professionals

Research

Co-investigator, R01 NS37167: Parkinson’s Disease Collaborative Study of Genetic Linkage (PROGENI study)

The goal of this collaboration between the Parkinson Study Group and geneticists at Indiana University and the University of Cincinnati is to investigate genetic factors that may be important in the development of Parkinson’s disease.

Dr. Rudolph is a Senior Project Coordinator in the Clinical Trials Coordination Center. In addition, Dr. Rudolph serves as liaison to administrative and research committees of the Parkinson Study Group, whose chair and executive director reside at the University of Rochester.

Academic Activity

Dr. Rudolph oversees the Clinical Trials Coordination Center’s Professional Development Workshop Series. She has made presentations at this series as well as at other clinical trials training meetings.

Comments

I am especially interested in helping to expand what is known about the causes, development, and treatment of neurodegenerative disorders such as Parkinson’s and Huntington’s disease. I have nothing but respect for the patients who selflessly volunteer to participate in the clinical trials investigating new treatments for these devastating diseases.